imatinib mesylate
NDC 0832-0533, imatinib mesylate, tablet, from Upsher-Smith Laboratories, LLC.
- Product NDC
- 0832-0533
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212135
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0832-0533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMATINIB MESYLATE400 mg/1
Pharmacologic classes
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0832-0533-03 | 00832053303 | 30 TABLET in 1 BOTTLE (0832-0533-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5d07ac08-962e-41a8-8a3c-50febc8c5f34NADAC price for package 00832053303
GET /v1/drugs/nadac/00832053303
Use it
Look up 0832-0533 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0832-0533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0832-0533. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.